Skip to main content

Retirement Group, LLC

SEC CIK
0001740491
Latest filing
Apr 30, 2024

ACAD holding history

Acadia Pharmaceuticals Inc in every 13F filed by Retirement Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACAD overviewAll 13F holders of ACADFull Q1 2024 holdings

Shares (Q1 2024)
600
Value
$1.55K
% of portfolio
<0.1%
Quarters held
13
Since Q1 2021
Holdings of ACAD by Retirement Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 2024600$1.55K<0.1%00.0%UnchangedHolders
Q4 2023600$1.50K<0.1%00.0%UnchangedHolders
Q3 2023600$1.22K<0.1%00.0%UnchangedHolders
Q2 2023600$1.38K<0.1%00.0%UnchangedHolders
Q1 2023600$2.00K<0.1%00.0%UnchangedHolders
Q4 2022600$1.00K<0.1%00.0%UnchangedHolders
Q3 2022600$1.00K<0.1%00.0%UnchangedHolders
Q2 2022600$2.00K<0.1%00.0%UnchangedHolders
Q1 2022600$2.00K<0.1%00.0%UnchangedHolders
Q4 2021600$2.00K<0.1%+100+20.0%AddedHolders
Q3 2021500$2.00K<0.1%−39−7.2%ReducedHolders
Q2 2021539$13.0K<0.1%00.0%UnchangedHolders
Q1 2021539$14.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.